⚠ COVID-19 INFORMATION: Resources, Vaccine Information

Treatment of calmodulinopathy with verapamil

Webster, G.; Schoppen, Z. J.; George, A. L., Jr.

BMJ Case Rep. 2017 Aug 9; 2017


Pathological variants in genes encoding calmodulin are associated with severe clinical presentations, including recurrent ventricular fibrillation and sudden death. Beta-receptor antagonists (beta-blockers) and sodium-channel antagonists have been reported as pharmacotherapies in these disorders; however, recent data have demonstrated the importance of derangements in calcium channel inactivation. We report a sustained attempt to use calcium-channel antagonists to treat calmodulinopathy and review the treatment strategies reported in the literature to date.

Read More on PubMed